{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:07:53Z","timestamp":1783022873670,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.semdp.2025.150944","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:00:10Z","timestamp":1754582410000},"page":"150944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differential diagnosis of multiple myeloma"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-4569","authenticated-orcid":false,"given":"Miguel Dario","family":"Cantu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semdp.2025.150944_bib0001","unstructured":"Ferry, J et al. Plasmacytoma. WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2024 (WHO classification of tumors series, 5th ed.; vol. 11). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/63. (2024)."},{"key":"10.1016\/j.semdp.2025.150944_bib0002","unstructured":"Kumar, S et al. Plasma cell myeloma \/multiple myeloma. WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2024 (WHO classification of tumors series, 5th ed.; vol. 11). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/63. (2024)."},{"key":"10.1016\/j.semdp.2025.150944_bib0003","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00428-022-03431-3","article-title":"Plasma cell neoplasms and related entities-evolution in diagnosis and classification","volume":"482","author":"Fend","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.semdp.2025.150944_bib0004","article-title":"Plasmablastic lymphoma","volume":"11","author":"Montes-Moreno","year":"2024"},{"key":"10.1016\/j.semdp.2025.150944_bib0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00428-022-03466-6","article-title":"Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities","volume":"482","author":"Song","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.semdp.2025.150944_bib0006","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.semdp.2025.150944_bib0007","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2643-3230.BCD-20-0051","article-title":"Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway","volume":"1","author":"Liu","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.semdp.2025.150944_bib0008","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.pathol.2018.03.011","article-title":"Colonic CD30 positive plasmablastic plasmacytoma masquerading as anaplastic large cell lymphoma","volume":"50","author":"Chang","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.semdp.2025.150944_bib0009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/PAS.0000000000002140","article-title":"Epstein-Barr virus-positive plasma cell neoplasms in immunocompetent patients: a clinicopathological study of 15 cases from South China and literature review","volume":"48","author":"Xiao","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semdp.2025.150944_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/his.12640","article-title":"Epstein-Barr virus-positive plasmacytoma in immunocompetent patients","volume":"67","author":"Loghavi","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.semdp.2025.150944_bib0011","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/his.13959","article-title":"High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma","volume":"76","author":"Miao","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.semdp.2025.150944_bib0012","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1309\/AJCPFUR1BK0UODTS","article-title":"Plasmablastic lymphomas with MYC\/IgH rearrangement: report of three cases and review of the literature","volume":"132","author":"Bogusz","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.semdp.2025.150944_bib0013","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/cncr.27551","article-title":"Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy","volume":"118","author":"Castillo","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.semdp.2025.150944_bib0014","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1038\/s41467-021-25405-w","article-title":"Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma","volume":"12","author":"Frontzek","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.semdp.2025.150944_bib0015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41375-019-0543-4","article-title":"MYC dysregulation in the progression of multiple myeloma","volume":"34","author":"Misund","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.semdp.2025.150944_bib0016","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3324\/haematol.2020.271957","article-title":"MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma","volume":"106","author":"Ramis-Zaldivar","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.semdp.2025.150944_bib0017","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3324\/haematol.2020.251579","article-title":"Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma","volume":"106","author":"Garcia-Reyero","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.semdp.2025.150944_bib0018","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1038\/bcj.2014.13","article-title":"Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients","volume":"4","author":"Walker","year":"2014","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.semdp.2025.150944_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms24044079","article-title":"DIS3: The Enigmatic Gene in Multiple Myeloma","volume":"24","author":"Ohguchi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.semdp.2025.150944_bib0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1309\/AJCPUS3PRRT5ZXVS","article-title":"Clinical, immunophenotypic, and genetic characterization of small lymphocyte\u2013Like plasma cell myeloma","volume":"133","author":"Heerema-Mckenney","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.semdp.2025.150944_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232674","article-title":"Morphology can be misleading\u2019: small lymphocyte-like plasma cell myeloma","volume":"12","author":"Sharma","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.semdp.2025.150944_bib0022","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5045\/br.2022.2022059","article-title":"A rare case of primary plasma cell leukemia exhibiting the small-cell variant of plasma cells","volume":"57","author":"Kim","year":"2022","journal-title":"Blood Res"},{"key":"10.1016\/j.semdp.2025.150944_bib0023","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/00000478-200608000-00004","article-title":"Mantle cell lymphoma with plasma cell differentiation","volume":"30","author":"Young","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semdp.2025.150944_bib0024","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.semdp.2025.150944_bib0025","first-page":"1","article-title":"Serum paraprotein is associated with adverse prognostic factors and outcome, across different subtypes of mature B-cell malignancies-A systematic review","author":"Cox","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semdp.2025.150944_bib0026","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.semdp.2025.150944_bib0027","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajh.23922","article-title":"Waldenstr\u00f6m macroglobulinemia: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Gertz","year":"2015","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150944_bib0028","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1309\/AJCP6ZODWV1CIDME","article-title":"Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature","volume":"143","author":"Bassarova","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.semdp.2025.150944_bib0029","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/annonc\/mdl109","article-title":"Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154\/CD40 signaling","volume":"17","author":"Tournilhac","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semdp.2025.150944_bib0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","article-title":"The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing","volume":"468","author":"Swerdlow","year":"2016","journal-title":"Virchows Arch"},{"issue":"9","key":"10.1016\/j.semdp.2025.150944_bib0031","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semdp.2025.150944_bib0032","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1501548","article-title":"Ibrutinib in previously treated Waldenstr\u00f6m\u2019s Macroglobulinemia","volume":"372","author":"Treon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semdp.2025.150944_bib0033","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1309\/AJCP63OGXHXCSKSC","article-title":"Marginal zone lymphomas with plasmacytic differentiation and related disorders","volume":"136","author":"Molina","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.semdp.2025.150944_bib0034","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.semdp.2025.150944_bib0035","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1084\/jem.20112203","article-title":"The nature of circulating CD27+CD43+ B cells","volume":"208","author":"Perez-Andres","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.semdp.2025.150944_bib0036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1703","article-title":"Gastrointestinal lymphoma: where morphology meets molecular biology","volume":"205","author":"Isaacson","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.semdp.2025.150944_bib0037","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2559.2007.02580.x","article-title":"Cytogenetic abnormalities in MALT lymphomas and their precursor lesions from different organs. A fluorescence in situhybridization (FISH) study","volume":"50","author":"Jo\u00e3o","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.semdp.2025.150944_bib0038","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s00277-019-03784-x","article-title":"Chronic lymphocytic leukemia with plasmacytic differentiation","volume":"98","author":"Lyapichev","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.semdp.2025.150944_bib0039","first-page":"467","article-title":"PRDM1\/BLIMP-1 expression in multiple B and T-cell lymphoma","volume":"91","author":"Garcia","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.semdp.2025.150944_bib0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/PAS.0000000000001399","article-title":"Unusual variants of follicular lymphoma","volume":"44","author":"Chapman","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semdp.2025.150944_bib0041","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/modpathol.2009.146","article-title":"Follicular lymphomas with plasmacytic differentiation include two subtypes","volume":"23","author":"Gradowski","year":"2010","journal-title":"Mod Pathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257025000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257025000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:32:19Z","timestamp":1763469139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257025000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0740257025000802"],"URL":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150944","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential diagnosis of multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150944"}}